AMTX vs FRD

AMTX exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile operational foundation. The absence of an Altman Z-Score and negative profitability metrics—especially a -38.96% profit margin and -8.96% ROA—signal severe operational distress. Despite a 14.2% YoY revenue growth and recent positive EPS surprises, the company remains unprofitable with negative cash flow and extreme liquidity issues (current ratio of 0.07). The stock trades at a price/sales of 0.77, but this is misleading given the lack of sustainable earnings and deteriorating balance sheet. The 52-week price range of $1.22–$3.66 reflects high volatility and speculative risk.

FRD presents a classic value-trap profile, characterized by a very weak Piotroski F-Score of 2/9 indicating deteriorating fundamental health despite explosive revenue growth of 78.6%. While the stock is objectively undervalued relative to its Graham Number ($31.6) and trades at a low P/E of 8.15, the razor-thin profit margins (2.68%) and bearish technical trend (0/100) offset the valuation appeal. The discrepancy between the high current ratio (3.59) and lower quick ratio (0.91) suggests a heavy reliance on inventory, which is risky in the cyclical steel industry. Overall, the strong top-line growth is not yet translating into fundamental financial strength.